Abstract
Fifty-seven patients with familial hypercholesterolemia (FH) with mean age of 48 years (range 30 to 69), participated in a follow-up examination 5.5 years after the completion of a 1-year trial with lovastatin, cholestyramine, probucol, or omega-3 fatty acids. The goals were to record quality of life, compliance to treatment, adverse effects, and clinical outcome. The quality of life was similar to that in a Norwegian reference population. The factors causing most distress to patients were keeping a diet low in saturated fats, taking medication, and fear of death. The medication was mostly prescribed in maximum dosages. At follow-up, the reduction in total cholesterol was 36% (p < 0.05), low-density lipoprotein (LDL) cholesterol 38% (p < 0.05), triglycerides 20% (p < 0.05) compared with being on diet therapy only. High-density lipoprotein (HDL) cholesterol increased 8% (p < 0.05). Intake of saturated and monounsaturated fat increased 1.5% and 1.7% (p < 0.05), respectively; polyunsaturated fat was unchanged. Three patients experienced myocardial infarction, of whom 2 died and 1 developed angina pectoris. Before the start of lovastatin treatment, 27 coronary events occurred per 1,000 patient-years in this group compared with 12 e...Continue Reading
References
Dec 19, 1990·JAMA : the Journal of the American Medical Association·J P KaneR J Havel
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K FolkersH Tamagawa
Aug 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·F A HuppertB J Elliott
Apr 4, 1986·Science·M S Brown, J L Goldstein
Nov 16, 1995·The New England Journal of Medicine·J ShepherdC J Packard
Jan 1, 1994·European Journal of Clinical Pharmacology·R LaaksonenJ J Himberg
May 1, 1994·Circulation·C HallM O Arnold
Sep 30, 1993·The American Journal of Cardiology·L GoldmanM C Weinstein
Citations
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·S RaoK Keyomarsi
Apr 11, 2008·International Journal of Technology Assessment in Health Care·Laura HyttinenTimo E Strandberg
Dec 5, 2008·Journal of Medicinal Food·Mee Young HongDavid Heber
Aug 18, 2000·Journal of Internal Medicine·S Tonstad, I Hjermann
Apr 16, 2002·Journal of Internal Medicine·G HollmanA G Olsson
Sep 18, 2007·The Journal of Nutritional Biochemistry·Mee Young HongDavid Heber
Mar 25, 2005·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·J A JacksonP Dalgarno
Sep 30, 1999·Experimental Cell Research·S RaoK Keyomarsi
Nov 5, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Vassilis H AletrasJohn N Yfantopoulos
Mar 6, 2012·Scientific Reports·Wai To FungPak Ho Henry Leung
Oct 30, 2015·Circulation·Samuel S GiddingUNKNOWN American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascula
Oct 21, 2004·The Cochrane Database of Systematic Reviews·L HooperS B J Ebrahim
Dec 12, 2002·The Journal of Biological Chemistry·Chinweike Ukomadu, Anindya Dutta
Aug 22, 2003·The Journal of Biological Chemistry·Chinweike Ukomadu, Anindya Dutta
Jul 30, 2002·The American Journal of Clinical Nutrition·Agot L AmundsenFady Y Ntanios
Sep 22, 2000·Atherosclerosis·A AdlouniN Ghalim